By expenditures
| Name | Title | Type |
|---|---|---|
| Dana Aschenbrenner | FINANCE DIRECTOR | Auditee |
| Brian Unsen | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 347531 | 2023 | 2025-03-24 | Eide Bailly LLP | $10.82M |
| 27011 | 2022 | 2023-09-06 | Eide Bailly LLP | $7.03M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 347531 | 2023 | 2025-03-24 | 1106009 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 1106008 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 1106007 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 1106006 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 1106005 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 1106004 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 1106003 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 1106002 | 2023-004 | Significant Deficiency | - | I |
| 347531 | 2023 | 2025-03-24 | 1106001 | 2023-004 | Significant Deficiency | - | I |
| 347531 | 2023 | 2025-03-24 | 1106000 | 2023-004 | Significant Deficiency | - | I |
| 347531 | 2023 | 2025-03-24 | 529567 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 529566 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 529565 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 529564 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 529563 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 529562 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 529561 | 2023-003 | Material Weakness | Yes | M |
| 347531 | 2023 | 2025-03-24 | 529560 | 2023-004 | Significant Deficiency | - | I |
| 347531 | 2023 | 2025-03-24 | 529559 | 2023-004 | Significant Deficiency | - | I |
| 347531 | 2023 | 2025-03-24 | 529558 | 2023-004 | Significant Deficiency | - | I |
| 27011 | 2022 | 2023-09-06 | 612387 | 2022-003 | Material Weakness | - | M |
| 27011 | 2022 | 2023-09-06 | 612386 | 2022-002 | Material Weakness | - | A |
| 27011 | 2022 | 2023-09-06 | 612385 | 2022-003 | Material Weakness | - | M |
| 27011 | 2022 | 2023-09-06 | 612384 | 2022-002 | Material Weakness | - | A |
| 27011 | 2022 | 2023-09-06 | 612383 | 2022-003 | Material Weakness | - | M |
| 27011 | 2022 | 2023-09-06 | 612382 | 2022-002 | Material Weakness | - | A |
| 27011 | 2022 | 2023-09-06 | 612381 | 2022-003 | Material Weakness | - | M |
| 27011 | 2022 | 2023-09-06 | 612380 | 2022-002 | Material Weakness | - | A |
| 27011 | 2022 | 2023-09-06 | 35945 | 2022-003 | Material Weakness | - | M |
| 27011 | 2022 | 2023-09-06 | 35944 | 2022-002 | Material Weakness | - | A |
| 27011 | 2022 | 2023-09-06 | 35943 | 2022-003 | Material Weakness | - | M |
| 27011 | 2022 | 2023-09-06 | 35942 | 2022-002 | Material Weakness | - | A |
| 27011 | 2022 | 2023-09-06 | 35941 | 2022-003 | Material Weakness | - | M |
| 27011 | 2022 | 2023-09-06 | 35940 | 2022-002 | Material Weakness | - | A |
| 27011 | 2022 | 2023-09-06 | 35939 | 2022-003 | Material Weakness | - | M |
| 27011 | 2022 | 2023-09-06 | 35938 | 2022-002 | Material Weakness | - | A |